全球脑磁图市场 - 2023-2030 年

市场概述

全球脑磁图市场规模在 2022 年达到 2.738 亿美元，预计到 2030 年将实现利润丰厚的增长，达到 4.088 亿美元。在预测期内（2023-2030 年），全球脑磁图市场预计将呈现 5.2% 的复合年增长率。

脑磁图对癫痫患者的检查和手术规划大有裨益。借助这项技术，可以找到致痫区，即导致癫痫发作的大脑活动异常的精确区域。这些信息对选择最佳手术方法至关重要，既能断开或切除受损脑组织，又能保护关键功能区。

市场动态

在预测期内，对脑部研究的日益关注推动了全球脑磁图市场的增长。

脑健康是一个不断变化的概念，越来越受到健康产业和普通大众的关注，这是有充分理由的。尽管阻止神经退行性病变导致晚年临床痴呆症的最大策略是早期发现和控制风险因素，但对大脑健康危害的研究仍主要集中在中老年人身上。

以社区为基础的脑健康管理服务为沟通和早期风险分析提供了新的机会。由此产生的大量数据将促进我们对痴呆症流行病学和治疗效果的了解。

临床诊断中越来越多的应用为全球脑磁图市场提供了增长机会。

脑磁图已被证明具有作为脑震荡临床诊断技术的潜力。脑磁图具有毫秒级的时间分辨率，是一种绘制大脑功能解剖图的非侵入性方法。它通过检测神经元电活动产生的磁场来实现这一目的。轴突束产生的突触后电位会产生具有磁场的细胞内电流，MEG 可以捕捉到这种电流。

MEG 利用遍布头骨表面的高精度精密传感器捕捉磁场。无需 X 射线、外部磁场或放射性同位素（用于核医学），即可生成图像。MEG 能够在位置和时间上区分正常和病态的大脑活动，是现有技术的一大进步。通过检测磁场，可以以无与伦比的毫秒级时间分辨率定位产生每个磁场的细胞组合。

COVID-19 影响分析

COVID-19 大流行对脑磁图市场产生了重大影响。大流行导致供应链中断、物流困难和财务不确定性。这些因素都可能导致脑磁图系统的安装和购置延迟。预算紧张的医院、研究机构和诊所，或因疫情而急需医疗保健服务的机构，可能会推迟或减少购买新的脑电图设备。

俄乌冲突分析

俄乌战争对脑磁成像市场的影响是复杂和多方面的。由于冲突造成的混乱，疾病监测和筛查计划难以成功实施。疾病监测和响应可能会受到阻碍，从而延误流行病的识别和遏制。

目 录

第 1 章：研究方法与范围

• 研究方法
• 报告的研究目标和范围

第2章：定义和概述

第3章：执行摘要

• 按应用分類的片段
• 按最终用户分类
• 按地区划分

第四章：动态

• 影响因素
  • 驱动因素
    • 痴呆症发病率上升
  • 制约因素
    • 与脑磁图相关的挑战
  • 机会
    • 在临床诊断中的应用不断增加
  • 影响分析

第 5 章：行业分析

• 波特五力分析
• 供应链分析
• 未满足的需求
• 监管分析

第 6 章：COVID-19 分析

• COVID-19 分析
  • COVID-19 之前的情景
  • COVID-19 期间的情景
  • COVID-19 后的情况
• COVID-19 期间的定价动态
• 供求关系
• 大流行期间与市场相关的政府倡议
• 制造商的战略倡议
• 结论

第 7 章 ：俄乌战争分析

第8章：人工智能分析

第9章：按应用分类

• 临床
  • 痴呆症
  • 自闭症
  • 精神分裂症
  • 多发性硬化症
  • 中风
  • 癫痫
  • 其他
• 研究

第10章：按最终用户分类

• 医院
• 影像诊断中心
• 学术和研究机构

第 11 章：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
• 中东和非洲

第 12 章 ：竞争格局

• 竞争格局
• 产品基准
• 公司份额分析
• 主要发展和战略

第 13 章 ：公司简介

• Compumedics Limited
  • 公司概况
  • 产品组合和说明
  • 财务概况
  • 主要发展
• MEGIN
• Ricoh USA, Inc.
• CTF MEG INTERNATIONAL SERVICES LP
• FieldLine Inc.
• Cerca Magnetics Limited
• Croton healthcare

第 14 章：附录

Market Overview

The global Magnetoencephalography Market reached US$ 273.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 408.8 million by 2030. The global Magnetoencephalography market is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).

The examination and surgical planning of individuals with epilepsy benefit greatly from Magnetoencephalography. The epileptogenic zone the precise area of aberrant brain activity that causes seizures can be located with the aid of this technique. This information is essential for selecting the best surgical approach to disconnect or remove damaged brain tissue while protecting critical functional regions.

Market Dynamics

Increased focus on brain research is boosting the global magnetoencephalography market growth during the forecast period.

Brain health is a concept that is always changing, gaining attention from the health industry as well as from the general public, and it does so for good reasons. Despite the greatest strategy to stop neurodegenerative changes that lead to clinical dementia later in life is early detection and control of risk factors, research on hazards to brain health still focuses on middle-aged and older persons.

New chances for communicating and early risk profiling are offered by community-based services for managing brain health. Large volumes of data will be produced as a result, advancing our knowledge of the epidemiology of dementia and the effectiveness of therapies.

Increasing applications in clinical diagnostics provide global magnetoencephalography market growth opportunities.

MEG has demonstrated potential as a clinical diagnostic technique for concussion in some patients. With a millisecond time resolution, MEG is a non-invasive method of mapping the functional anatomy of the brain. It does this by detecting magnetic fields produced by neuronal electrical activity. Postsynaptic potentials generated by bundles of axons result in intracellular currents with a magnetic field that can be picked up by MEG.

Magnetic fields are captured by MEG using highly accurate and sophisticated sensors throughout the surface of the skull. Without the need for X-rays, external magnetic fields, or radioactive isotopes (used in nuclear medicine), images can be produced. In its capacity to distinguish between normal and pathological brain activity in location and time, MEG advances existing technology. The cell assemblies that create each field may be located with an unmatched millisecond temporal resolution by detecting the magnetic fields.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the magnetoencephalography market. The pandemic has caused supply chain disruptions, logistical difficulties, and financial uncertainty. These elements might have contributed to a delay in the installation and acquisition of MEG systems. Hospitals, research facilities, and clinics with tight budgets or those attending to the pressing healthcare need brought on by the epidemic may have delayed or scaled back purchases of new MEG equipment.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the magnetoencephalography market is complex and multifaceted. Because of the disruption caused by the conflict, illness surveillance, and screening initiatives are difficult to successfully implement. Disease surveillance and response could be hampered, which could delay the identification and containment of epidemics.

Segment Analysis

The global magnetoencephalography market is segmented based on application, end-user, and region.

The clinical segment is expected to hold a dominant position in the market over the forecast period.

The clinical segment accounted for the highest market stake accounting for approximately 57.8% of the Magnetoencephalography market in 2022. Around the world, Alzheimer's disease (AD) accounts for 60% of all occurrences of dementia, making it the most common cause of the illness. With age, there is a higher chance of acquiring AD. In terms of source localization, MEG clearly gives a benefit.

The potential of MEG to predict conversion across the several stages of the disease (preclinical-prodromal-dementia) is a key aspect to take into account when using MEG as a biomarker for AD. There aren't many longitudinal studies and those that do all addressed the transition from MCI to dementia.

Geographical Analysis

Advancements in magnetoencephalography dominate the European region.

Europe is expected to dominate the magnetoencephalography market, accounting for around 27.8% of this market. No external fields or injections are used in the MEG process; instead, it detects magnetic fields that the brain naturally produces. The most sophisticated clinical use of MEG is for epilepsy diagnosis.

Epilepsy affects six million individuals in Europe alone, and there are roughly 300,000 new cases every year. There are more applications for MEG, such as the diagnosis of mild traumatic brain injuries (TBI), which accounts for more than half of the 2.5 million new TBI cases in Europe each year.

Competitive Landscape

The major global players in the market include: Compumedics Limited, MEGIN, Ricoh USA, Inc., CTF MEG INTERNATIONAL SERVICES LP, FieldLine Inc., Cerca Magnetics Limited, and Croton Healthcare among others.

Why Purchase the Report?

• To visualize the global magnetoencephalography market segmentation based on the application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of magnetoencephalography market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global magnetoencephalography market report would provide approximately 44 tables, 43 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Application
• 3.2. Snippet by End-user
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The increasing incidence of dementia
  • 4.1.2. Restraints
    • 4.1.2.1. Challenges associated with magnetoencephalography
  • 4.1.3. Opportunity
    • 4.1.3.1. The increasing applications in clinical diagnostics
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Unmet Needs
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Clinical*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.2.3. Dementia
  • 9.2.4. Autism
  • 9.2.5. Schizophrenia
  • 9.2.6. Multiple Sclerosis
  • 9.2.7. Stroke
  • 9.2.8. Epilepsy
  • 9.2.9. Others
• 9.3. Research

10. By End-user

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 10.1.2. Market Attractiveness Index, By End-user
• 10.2. Hospitals*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Diagnostic Imaging centers
• 10.4. Academic and Research Institutes

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.5.1. U.S.
    • 11.2.5.2. Canada
    • 11.2.5.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.5.1. Germany
    • 11.3.5.2. U.K.
    • 11.3.5.3. France
    • 11.3.5.4. Italy
    • 11.3.5.5. Spain
    • 11.3.5.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.5.1. Brazil
    • 11.4.5.2. Argentina
    • 11.4.5.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.5.1. China
    • 11.5.5.2. India
    • 11.5.5.3. Japan
    • 11.5.5.4. Australia
    • 11.5.5.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Product Benchmarking
• 12.3. Company Share Analysis
• 12.4. Key Developments and Strategies

13. Company Profiles

• 13.1. Compumedics Limited*
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. MEGIN
• 13.3. Ricoh USA, Inc.
• 13.4. CTF MEG INTERNATIONAL SERVICES LP
• 13.5. FieldLine Inc.
• 13.6. Cerca Magnetics Limited
• 13.7. Croton healthcare

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us